Annual growth rate of pharmaceutical spending in Japan FY 2018-2024

The pharmaceutical spend in Japan grew by around 2.9 percent in fiscal year 2019 compared to the previous fiscal year, even though the impact of the coronavirus disease (COVID-19) hit the country in the last quarter. The spending in fiscal 2020 was forecasted to drop by around two percent considering the further impact of COVID-19. According to the source, the major factor impacting on the pharmaceutical spend would be a decrease in non-COVID-19-related patient visits and doctor consultations.

在日本，相较于上一年度，2019财年医药支出增长了约2.9%，尽管新冠病毒疾病（COVID-19）的影响在年末的最后季度波及该国。鉴于COVID-19的进一步影响，2020财年的医药支出预计将下降约2%。据来源分析，影响医药支出的主要因素将是与COVID-19无关的患者就诊和医生咨询量的减少。